Select Publications
Conference Papers
2024, '181 Age-related risk of serious fall events associated with opioid analgesic use', in Abstracts, BMJ Publishing Group Ltd, pp. A35.1 - A35, presented at 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) abstracts, http://dx.doi.org/10.1136/injuryprev-2024-safety.83
,2022, '| New South Wales, Long-term trajectories of prescription opioid use in New South Wales, Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 371 - 372, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084401349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'POPPY II cohort profile- a population-based linked cohort examining the course and outcomes of prescription opioid use in NSW, Australia, 2003-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 300 - 301, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300611&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'The safety of transdermal fentanyl initiation in Australian clinical practice', Brisbane, Australia, presented at 2017 Australasian Pharmaceutical Scientific Association - Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Joint Scientific Meeting, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'Quantifying the extent that data from PBS/RPBS claims under-estimate opioid analgesic utilisation in Australia', Brisbane, Australia, presented at 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, 29 October 2017 - 31 October 2017
,2017, 'An ecological study of the extent and factors associated with the use of fentanyl across Australia', Brisbane, Australia, presented at 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, 29 October 2017 - 31 October 2017
,2016, 'Does Size Really Matter? Using Big Data to Examine the Patterns and Predictors of Opioid Utilisation in Australia', Sydney, Australia, presented at 2016 Australasian Pharmaceutical Science Association Annual Conference, Sydney, Australia, 02 December 2016 - 05 December 2016
,2015, 'An ecological study of the extent and factors associated with use of prescription and over-the-counter codeine in Australia', presented at 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, 29 November 2015 - 02 December 2015
,2015, 'Opioid Substitution Therapy among Prisoners: Longitudinal Findings from a Data Linkage Study', Hobart, Australia, presented at 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, Hobart, Australia, 29 November 2015 - 02 December 2015
,2015, 'A cost-effectiveness analysis of opioid substitution therapy upon release from prison', presented at 2015 Australasian Professional Society on Alcohol and Other Drugs Conference, 08 November 2015 - 11 November 2015
,2015, 'Estimating the extent and predictors of pharmaceutical opioid use in Australia in 2013', presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015
,2015, 'The effect of treatment and retention with opioid substitution therapy in reducing crime among opioid-dependent people', presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015
,2014, 'Treatment utilisation and retention with opioid substitution therapy: comparison of buprenorphine and methadone users', presented at 2014 Australasian Professional Society on Alcohol and Other Drugs Conference, 09 November 2014 - 12 November 2014
,2014, 'The impact of opioid substitution therapy on mortality post-release from prison: A retrospective data linkage study', presented at 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 24 October 2014 - 27 October 2014
,2014, 'Treatment utilisation and retention with opioid substitution therapy between 2001 and 2010: A comparison of buprenorphine and methadone users', presented at 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 24 October 2014 - 27 October 2014
,2014, 'The cost effectiveness of opioid substitution therapy and impact on criminal offending and mortality.', presented at National Drug and Alcohol Research Centre 2014 Annual Symposium, 08 September 2014 - 08 September 2014
,2011, 'COMMUNITY TREATMENT ORDERS FOR INDIVIDUALS WITH A MENTAL ILLNESS IN NEW SOUTH WALES: A DESCRIPTIVE ANALYSIS OF PSYCHOTROPIC DRUG USE', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, pp. A36 - A36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290992200113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,